Archive for the ‘CepTor Corp. CEPO’ Category

Beacon Equity Research Featured Company: CepTor Corp. (CEPO.OB)

Tuesday, December 18th, 2007

CepTor Corp. is a biopharmaceutical Company focused on discovering, developing, and commercializing proprietary cell-targeted therapeutic products. The Company’s drugs are designed to treat neuromuscular and neurodegenerative diseases in addition to rare orphan diseases.

Each executive leading the company has over 20 years of experience in their fields of expertise and have proven track records of previous successes. The management team also has extensive knowledge in the regulatory aspects inbuilt in orphan drug development and commercialization.

CepTor plans to identify global partnerships for the strategic commercialization of its non-orphan products while staying focused on its in-house development. The business model used will position CepTor to take advantage of the high return orphan drug market.

Let us hear your thoughts: CepTor Corp. Message Board